GL1X · GenesisL1 explorer

MolNFT v1 · #124700 · protein

Ctx-M-9 beta lactamase mutant - T165W

5KMU · Beta-lactamase: “Ctx-M-9 beta lactamase mutant - T165W”. X-ray diffraction, 2 ligands (PO4, CL), 1 pocket (best druggability 0.30). MolNFT v1 #124700 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5KMU
Type
protein
Length
261 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q9L5C8
Ligands
PO4, CL
Pockets
1 · best druggability 0.30

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein26144% helix, 19% strandQ9L5C8

Ligands and binding sites

  • PO4 · Phosphate ion · ion · 4 copies · chains A
  • CL · Chloride ion · ion · chains A
  • PEG · Di(hydroxyethyl)ether · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1670.300.7517PO4

Compared structures

  • 5KMU · CTX-M-9 beta lactamase mutant - T165W · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.